Postbiotics versus probiotics in early-onset colorectal cancer

References

• Abbasi, A., A. H. Rad, Z. Ghasempour, S. Sabahi, H. S. Kafil, P. Hasannezhad, Y. R. Saadat, and N. Shahbazi. 2021. The biological activities of postbiotics in gastrointestinal disorders. Critical Reviews in Food Science and Nutrition 10:1–13. doi: 10.1080/10408398.2021.1935701.[Mismatch]
   Google Scholar
• Abdalla, A. K., M. M. Ayyash, A. N. Olaimat, T. M. Osaili, A. A. Al-Nabulsi, N. P. Shah, and R. Holley. 2021. Exopolysaccharides as antimicrobial agents: Mechanism and spectrum of activity. Frontiers in Microbiology 12:664395. doi: 10.3389/fmicb.2021.664395.
   PubMed Web of Science ®Google Scholar
• Abdullah, M., N. Sukartini, S. A. Nursyirwan, R. R. Pribadi, H. Maulahela, A. P. Utari, V. N. Muzellina, A. Wiraatmadja, and K. Renaldi. 2021. Gut microbiota profiles in early- and late-onset colorectal cancer: A potential diagnostic biomarker in the future. Digestion 102 (6):823–32. doi: 10.1159/000516689.
   PubMed Web of Science ®Google Scholar
• Aguilar-Toalá, J. E., S. Arioli, P. Behare, C. Belzer, R. Berni Canani, J.-M. Chatel, E. D’Auria, M. Q. de Freitas, E. Elinav, E. A. Esmerino, et al. 2021. Postbiotics—When simplification fails to clarify. Nature Reviews. Gastroenterology & Hepatology 18 (11):825–6. doi: 10.1038/s41575-021-00521-6.
   PubMed Web of Science ®Google Scholar
• Aguilar-Toalá, J. E., R. Garcia-Varela, H. S. Garcia, V. Mata-Haro, A. F. González-Córdova, B. Vallejo-Cordoba, and A. Hernández-Mendoza. 2018. Postbiotics: An evolving term within the functional foods field. Trends in Food Science & Technology 75:105–14. doi: 10.1016/j.tifs.2018.03.009.
   Web of Science ®Google Scholar
• Ahmad Kendong, S. M., R. A. Raja Ali, K. N. M. Nawawi, H. F. Ahmad, and N. M. Mokhtar. 2021. Gut dysbiosis and intestinal barrier dysfunction: Potential explanation for early-onset colorectal cancer. Frontiers in Cellular and Infection Microbiology 11:744606. doi: 10.3389/fcimb.2021.744606.
   PubMed Web of Science ®Google Scholar
• Akimoto, N., T. Ugai, R. Zhong, T. Hamada, K. Fujiyoshi, M. Giannakis, K. Wu, Y. Cao, K. Ng, and S. Ogino. 2021. Rising incidence of early-onset colorectal cancer – A call to action. Nature Reviews Clinical Oncology 18 (4):230–43. doi: 10.1038/s41571-020-00445-1.
   PubMed Web of Science ®Google Scholar
• Aponte, M., N. Murru, and M. Shoukat. 2020. Therapeutic, prophylactic, and functional use of probiotics: A current perspective. Frontiers in Microbiology 11:562048. doi: 10.3389/fmicb.2020.562048.
   PubMed Web of Science ®Google Scholar
• Archambault, A. N., Y. Lin, J. Jeon, T. A. Harrison, D. T. Bishop, H. Brenner, G. Casey, A. T. Chan, J. Chang-Claude, J. C. Figueiredo, et al. 2021. Nongenetic determinants of risk for early-onset colorectal cancer. JNCI Cancer Spectrum 5 (3):pkab029. doi: 10.1093/jncics/pkab029.
   PubMed Web of Science ®Google Scholar
• Ayichew, T., A. Belete, T. Alebachew, H. Tsehaye, H. Berhanu, and A. Minwuyelet. 2017. Bacterial probiotics their importances and limitations: A review. Journal of Nutrition and Health Sciences 4 (2):202.
   Google Scholar
• Bafeta, A., M. Koh, C. Riveros, and P. Ravaud. 2018. Harms reporting in randomized controlled trials of interventions aimed at modifying microbiota: A systematic review. Annals of Internal Medicine 169 (4):240–7. doi: 10.7326/m18-0343.
   PubMed Web of Science ®Google Scholar
• Ballester, V., S. Rashtak, and L. Boardman. 2016. Clinical and molecular features of young-onset colorectal cancer. World Journal of Gastroenterology 22 (5):1736–44. doi: 10.3748/wjg.v22.i5.1736.
   PubMed Web of Science ®Google Scholar
• Banerjee, S. 2021. Recommendation and limitation of probiotics supplements. Current Trends in Pharmacy and Pharmaceutical Chemistry 3 (3):19–22. doi: 10.18231/j.ctppc.2021.006.
   Google Scholar
• Bauer, J. A., M. Salvagni, L. Vigroux, J.-P, L. Chalvet, and C. Chiavaroli. 2015. Bacterial extract for digestive or urinary tract disorders and process for its preparation. In: Google Patents.
   Google Scholar
• Bhadoria, P., and S. Mahapatra. 2011. Prospects, technological aspects and limitations of probiotics – A worldwide review. European Journal of Nutrition & Food Safety 1 (2):23–42.
   Google Scholar
• Braido, F., F. Tarantini, V. Ghiglione, G. Melioli, and G. Canonica. 2007. Bacterial lysate in the prevention of acute exacerbation of COPD and in respiratory recurrent infections. International Journal of Chronic Obstructive Pulmonary Disease 2 (3):335–45.
   PubMedGoogle Scholar
• Canani, R. B., M. D. Costanzo, L. Leone, M. Pedata, R. Meli, and A. Calignano. 2011. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World Journal of Gastroenterology 17 (12):1519–28. doi: 10.3748/wjg.v17.i12.1519.
   PubMed Web of Science ®Google Scholar
• Cazzola, M., P. Rogliani, and G. Curradi. 2008. Bacterial extracts for the prevention of acute exacerbations in chronic obstructive pulmonary disease: A point of view. Respiratory Medicine 102 (3):321–7.
   PubMed Web of Science ®Google Scholar
• Chang, V. C., M. Cotterchio, P. De, and J. Tinmouth. 2021. Risk factors for early-onset colorectal cancer: A population-based case-control study in Ontario, Canada. Cancer Causes & Control 32 (10):1063–83. doi: 10.1007/s10552-021-01456-8.
   PubMed Web of Science ®Google Scholar
• Chen, H., X. Zheng, X. Zong, Z. Li, N. Li, J. Hur, C. D. Fritz, W. Chapman, Jr., K. B. Nickel, A. Tipping, et al. 2021. Metabolic syndrome, metabolic comorbid conditions and risk of early-onset colorectal cancer. Gut 70 (6):1147–54. doi: 10.1136/gutjnl-2020-321661.
   PubMed Web of Science ®Google Scholar
• Cheng, E., H. N. Blackburn, K. Ng, D. Spiegelman, M. L. Irwin, X. Ma, C. P. Gross, F. K. Tabung, E. L. Giovannucci, P. L. Kunz, et al. 2021. Analysis of survival among adults with early-onset colorectal cancer in the National Cancer Database. JAMA Network Open 4 (6):e2112539. doi: 10.1001/jamanetworkopen.2021.12539.
   PubMed Web of Science ®Google Scholar
• Di, W., L. Zhang, S. Wang, H. Yi, X. Han, R. Fan, and Y. Zhang. 2017. Physicochemical characterization and antitumour activity of exopolysaccharides produced by Lactobacillus casei SB27 from yak milk. Carbohydrate Polymers 171:307–15. doi: 10.1016/j.carbpol.2017.03.018.
   PubMed Web of Science ®Google Scholar
• Dore, M. P., S. Bibbò, G. Fresi, G. Bassotti, and G. M. Pes. 2019. Side effects associated with probiotic use in adult patients with inflammatory bowel disease: A systematic review and meta-analysis of randomized controlled trials. Nutrients 11 (12):2913. doi: 10.3390/nu11122913.
   PubMed Web of Science ®Google Scholar
• El-Deeb, N. M., A. M. Yassin, L. A. Al-Madboly, and A. El-Hawiet. 2018. A novel purified Lactobacillus acidophilus 20079 exopolysaccharide, LA-EPS-20079, molecularly regulates both apoptotic and NF-κB inflammatory pathways in human colon cancer. Microbial Cell Factories 17 (1):29. doi: 10.1186/s12934-018-0877-z.
   PubMedGoogle Scholar
• Fong, W., Q. Li, and J. Yu. 2020. Gut microbiota modulation: A novel strategy for prevention and treatment of colorectal cancer. Oncogene 39 (26):4925–43. doi: 10.1038/s41388-020-1341-1.
   PubMed Web of Science ®Google Scholar
• Gao, R., Z. Gao, L. Huang, and H. Qin. 2017. Gut microbiota and colorectal cancer. European Journal of Clinical Microbiology & Infectious Diseases 36 (5):757–69. doi: 10.1007/s10096-016-2881-8.
   PubMed Web of Science ®Google Scholar
• Gao, Z.-Y., Z. Cui, Y.-Q. Yan, L.-J. Ning, Z.-H. Wang, and J. Hong. 2021. Microbe-based management for colorectal cancer. Chinese Medical Journal 134 (24):2922–30. doi: 10.1097/cm9.0000000000001887.
   PubMed Web of Science ®Google Scholar
• Gholizadeh, P., M. Mahallei, A. Pormohammad, M. Varshochi, K. Ganbarov, E. Zeinalzadeh, B. Yousefi, M. Bastami, A. Tanomand, S. S. Mahmood, et al. 2019. Microbial balance in the intestinal microbiota and its association with diabetes, obesity and allergic disease. Microbial Pathogenesis 127:48–55. doi: 10.1016/j.micpath.2018.11.031.
   PubMed Web of Science ®Google Scholar
• Hajiagha, M. N., S. Taghizadeh, M. Asgharzadeh, S. Dao, K. Ganbarov, Ş. Köse, and H. S. Kafil. 2022. Gut microbiota and human body interactions; Its impact on health: A review. Current Pharmaceutical Biotechnology 23 (1):4–14. doi: 10.2174/1389201022666210104115836.
   PubMed Web of Science ®Google Scholar
• Hernández-Granados, M. J., and E. Franco-Robles. 2020. Postbiotics in human health: Possible new functional ingredients? Food Research International 137:109660. doi: 10.1016/j.foodres.2020.109660.
   PubMed Web of Science ®Google Scholar
• Hills, R. D., Jr., B. A. Pontefract, H. R. Mishcon, C. A. Black, S. C. Sutton, and C. R. Theberge. 2019. Gut microbiome: Profound implications for diet and disease. Nutrients 11 (7):1613. doi: 10.3390/nu11071613.
   PubMed Web of Science ®Google Scholar
• Hofseth, L. J., J. R. Hebert, A. Chanda, H. Chen, B. L. Love, M. M. Pena, E. A. Murphy, M. Sajish, A. Sheth, P. J. Buckhaults, et al. 2020. Early-onset colorectal cancer: Initial clues and current views. Nature Reviews Gastroenterology & Hepatology 17 (6):352–64. doi: 10.1038/s41575-019-0253-4.
   PubMed Web of Science ®Google Scholar
• Holst, O., and S. Müller-Loennies. 2007. 1.04 – Microbial polysaccharide structures. In Comprehensive glycoscience, ed. H. Kamerling, 123–79. Oxford: Elsevier.
   Google Scholar
• Homayouni Rad, A., L. Aghebati Maleki, H. Samadi Kafil, H. Fathi Zavoshti, and A. Abbasi. 2021. Postbiotics as promising tools for cancer adjuvant therapy. Advanced Pharmaceutical Bulletin 11 (1):1–5. doi: 10.34172/apb.2021.007.
   PubMed Web of Science ®Google Scholar
• Hur, J., E. Otegbeye, H.-K. Joh, K. Nimptsch, K. Ng, S. Ogino, J. A. Meyerhardt, A. T. Chan, W. C. Willett, K. Wu, et al. 2021. Sugar-sweetened beverage intake in adulthood and adolescence and risk of early-onset colorectal cancer among women. Gut 70 (12):2330–6. doi: 10.1136/gutjnl-2020-323450.
   PubMed Web of Science ®Google Scholar
• Illartein, P.-R. 1971. Pharmaceutical preparation based on bacterial antigens. In: Google Patents.
   Google Scholar
• Jiminez, J. A., T. C. Uwiera, D. W. Abbott, R. R. E. Uwiera, G. D. Inglis, and G. Suen. 2017. Butyrate supplementation at high concentrations alters enteric bacterial communities and reduces intestinal inflammation in mice infected with Citrobacter rodentium. mSphere 2 (4):e00243. doi: 10.1128/mSphere.00243-17.
   PubMed Web of Science ®Google Scholar
• Kaur, S., S. K. Thukral, P. Kaur, and M. K. Samota. 2021. Perturbations associated with hungry gut microbiome and postbiotic perspectives to strengthen the microbiome health. Future Foods 4:100043. doi: 10.1016/j.fufo.2021.100043.
   Google Scholar
• Kim, S., G.-H. Kim, and H. Cho. 2021. Postbiotics for cancer prevention and treatment. The Microbiological Society of Korea 57 (3):142–53.
   Google Scholar
• Konishi, H., M. Fujiya, H. Tanaka, N. Ueno, K. Moriichi, J. Sasajima, K. Ikuta, H. Akutsu, H. Tanabe, and Y. Kohgo. 2016. Probiotic-derived ferrichrome inhibits colon cancer progression via JNK-mediated apoptosis. Nature Communications 7:12365. doi: 10.1038/ncomms12365.
   PubMed Web of Science ®Google Scholar
• Kothari, D., S. Patel, and S.-K. Kim. 2019. Probiotic supplements might not be universally-effective and safe: A review. Biomedicine & Pharmacotherapy 111:537–47. doi: 10.1016/j.biopha.2018.12.104.
   PubMed Web of Science ®Google Scholar
• Li, H.-Y., D.-D. Zhou, R.-Y. Gan, S.-Y. Huang, C.-N. Zhao, A. Shang, X.-Y. Xu, and H.-B. Li. 2021. Effects and mechanisms of probiotics, prebiotics, synbiotics, and postbiotics on metabolic diseases targeting gut microbiota: A narrative review. Nutrients 13 (9):3211. doi: 10.3390/nu13093211.
   PubMed Web of Science ®Google Scholar
• Lu, K., S. Dong, X. Wu, R. Jin, and H. Chen. 2021. Probiotics in cancer. Frontiers in Oncology 11:638148. doi: 10.3389/fonc.2021.638148.
   PubMed Web of Science ®Google Scholar
• Ma, F., Y. Song, M. Sun, A. Wang, S. Jiang, G. Mu, and Y. Tuo. 2021. Exopolysaccharide produced by Lactiplantibacillus plantarum-12 alleviates intestinal inflammation and colon cancer symptoms by modulating the gut microbiome and metabolites of C57BL/6 mice treated by azoxymethane/dextran sulfate sodium salt. Foods 10 (12):3060. doi: 10.3390/foods10123060.
   PubMed Web of Science ®Google Scholar
• Maftei, N.-M. 2019. Probiotic, prebiotic and synbiotic products in human health. In Frontiers and new trends in the science of fermented food and beverages, by R. L. Solís-Oviedo, and Ángel De La Cruz Pech-Canul, 47–66. London, United Kingdom: IntechOpen.
   Google Scholar
• Marco, M. L., M. E. Sanders, M. Gänzle, M. C. Arrieta, P. D. Cotter, L. De Vuyst, C. Hill, W. Holzapfel, S. Lebeer, D. Merenstein, et al. 2021. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on fermented foods. Nature Reviews. Gastroenterology & Hepatology 18 (3):196–208. doi: 10.1038/s41575-020-00390-5.
   PubMed Web of Science ®Google Scholar
• Markowiak, P., and K. Śliżewska. 2017. Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients 9 (9):1021. doi: 10.3390/nu9091021.
   PubMed Web of Science ®Google Scholar
• Marteau, P., and P. Seksik. 2004. Tolerance of probiotics and prebiotics. Journal of Clinical Gastroenterology 38 (6 Suppl):S67–S69. doi: 10.1097/01.mcg.0000128929.37156.a7.
   PubMed Web of Science ®Google Scholar
• Martyniak, A., A. Medyńska-Przęczek, A. Wędrychowicz, S. Skoczeń, and P. J. Tomasik. 2021. Prebiotics, probiotics, synbiotics, paraprobiotics and postbiotic compounds in IBD. Biomolecules 11 (12):1903. doi: 10.3390/biom11121903.
   PubMed Web of Science ®Google Scholar
• Mayorgas, A., I. Dotti, and A. Salas. 2021. Microbial metabolites, postbiotics, and intestinal epithelial function. Molecular Nutrition & Food Research 65 (5):2000188. doi: 10.1002/mnfr.202000188.
   Web of Science ®Google Scholar
• McDowell, R., S. Perrott, P. Murchie, C. Cardwell, C. Hughes, and L. Samuel. 2022. Oral antibiotic use and early-onset colorectal cancer: Findings from a case-control study using a national clinical database. British Journal of Cancer 126 (6):957–67. doi: 10.1038/s41416-021-01665-7.
   PubMed Web of Science ®Google Scholar
• Nagpal, R., A. Kumar, M. Kumar, P. V. Behare, S. Jain, and H. Yadav. 2012. Probiotics, their health benefits and applications for developing healthier foods: A review. FEMS Microbiology Letters 334 (1):1–15. doi: 10.1111/j.1574-6968.2012.02593.x.
   PubMed Web of Science ®Google Scholar
• Nataraj, B. H., S. A. Ali, P. V. Behare, and H. Yadav. 2020. Postbiotics-parabiotics: The new horizons in microbial biotherapy and functional foods. Microbial Cell Factories 19 (1):168. doi: 10.1186/s12934-020-01426-w.
   PubMed Web of Science ®Google Scholar
• Niccolai, E., S. Baldi, F. Ricci, E. Russo, G. Nannini, M. Menicatti, G. Poli, A. Taddei, G. Bartolucci, A. S. Calabrò, et al. 2019. Evaluation and comparison of short chain fatty acids composition in gut diseases. World Journal of Gastroenterology 25 (36):5543–58. doi: 10.3748/wjg.v25.i36.5543.
   PubMed Web of Science ®Google Scholar
• Niida, A., K. Mimori, T. Shibata, and S. Miyano. 2021. Modeling colorectal cancer evolution. Journal of Human Genetics 66 (9):869–78. doi: 10.1038/s10038-021-00930-0.
   PubMed Web of Science ®Google Scholar
• Nozari, S., Y. Faridvand, A. Etesami, M. Ahmad Khan Beiki, S. A. Miresmaeili Mazrakhondi, and J. Abdolalizadeh. 2019. Potential anticancer effects of cell wall protein fractions from Lactobacillus paracasei on human intestinal Caco-2 cell line. Letters in Applied Microbiology 69 (3):148–54. doi: 10.1111/lam.13198.
   PubMed Web of Science ®Google Scholar
• O’Sullivan, D. E., R. L. Sutherland, S. Town, K. Chow, J. Fan, N. Forbes, S. J. Heitman, R. J. Hilsden, and D. R. Brenner. 2021. Risk factors for early-onset colorectal cancer: A systematic review and meta-analysis. Clinical Gastroenterology and Hepatology. doi: 10.1016/j.cgh.2021.01.037.
   PubMedGoogle Scholar
• Ozma, M. A., A. Abbasi, S. Akrami, M. Lahouty, N. Shahbazi, K. Ganbarov, P. Pagliano, S. Sabahi, Ş. Köse, M. Yousefi, et al. 2022. Postbiotics as the key mediators of the gut microbiota-host interactions. Le Infezioni in Medicina 30 (2):180–93.
   PubMedGoogle Scholar
• Phang, R. 2021. Nutritional immunity: Butyrate and colon carcinogenesis. Thesis, Bachelor of Biomedical Sciences with Honours, University of Otago. http://hdl.handle.net/10523/12424.
   Google Scholar
• Pillich, J., and J. C. Balcarek. 2013. Compositions and methods for treating of microbial infections. In: Google Patents.
   Google Scholar
• Puzzono, M., A. Mannucci, S. Grannò, R. A. Zuppardo, A. Galli, S. Danese, and G. M. Cavestro. 2021. The role of diet and lifestyle in early-onset colorectal cancer: A systematic review. Cancers 13 (23):5933. doi: 10.3390/cancers13235933.
   PubMed Web of Science ®Google Scholar
• Rad, A. H., L. Aghebati-Maleki, H. S. Kafil, and A. Abbasi. 2021. Molecular mechanisms of postbiotics in colorectal cancer prevention and treatment. Critical Reviews in Food Science and Nutrition 61 (11):1787–803. doi: 10.1080/10408398.2020.1765310.
   PubMed Web of Science ®Google Scholar
• Rahbar Saadat, Y., A. Yari Khosroushahi, A. A. Movassaghpour, M. Talebi, and B. Pourghassem Gargari. 2020. Modulatory role of exopolysaccharides of Kluyveromyces marxianus and Pichia kudriavzevii as probiotic yeasts from dairy products in human colon cancer cells. Journal of Functional Foods 64:103675. doi: 10.1016/j.jff.2019.103675.
   Web of Science ®Google Scholar
• Riaz Rajoka, M. S., H. Zhao, H. M. Mehwish, N. Li, Y. Lu, Z. Lian, D. Shao, M. Jin, Q. Li, L. Zhao, et al. 2019. Anti-tumor potential of cell free culture supernatant of Lactobacillus rhamnosus strains isolated from human breast milk. Food Research International 123:286–97. doi: 10.1016/j.foodres.2019.05.002.
   PubMed Web of Science ®Google Scholar
• Rogers, J. E., and B. Johnson. 2021. The reality of early-onset colorectal cancer: Highlighting the needs in a unique but emerging population. Digestive Medicine Research 4:63– doi: 10.21037/dmr-21-77.
   PubMedGoogle Scholar
• Romario-Silva, D., O. A. S. Sakaguchi, A. C. B. da Silva, J. O. Sardi, R. P. de Carvalho, S. M. Roque, L. P. S. Borges, R. B. E. Lins, L. T. Campos, and E. M. M. de Brito Costa. 2021. Probiotics as potential antimicrobials for the treatment of infections: Current reality or remote future?. In Prebiotics and probiotics – From food to health. IntechOpen.
   Google Scholar
• Rosenberg, K. 2021. Sugar-sweetened beverage intake linked to early-onset colorectal cancer risk. The American Journal of Nursing 121 (10):52. doi: 10.1097/01.NAJ.0000794268.40128.c1.
   Google Scholar
• Salami, M. 2021. Interplay of good bacteria and central nervous system: Cognitive aspects and mechanistic considerations. Frontiers in Neuroscience 15:613120. doi: 10.3389/fnins.2021.613120.
   PubMed Web of Science ®Google Scholar
• Salminen, S., M. C. Collado, A. Endo, C. Hill, S. Lebeer, E. M. M. Quigley, M. E. Sanders, R. Shamir, J. R. Swann, H. Szajewska, et al. 2021a. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nature Reviews. Gastroenterology & Hepatology 18 (9):649–67. doi: 10.1038/s41575-021-00440-6.
   PubMed Web of Science ®Google Scholar
• Salminen, S., M. C. Collado, A. Endo, C. Hill, S. Lebeer, E. M. M. Quigley, M. E. Sanders, R. Shamir, J. R. Swann, H. Szajewska, et al. 2021b. Reply to: Postbiotics – When simplification fails to clarify. Nature Reviews. Gastroenterology & Hepatology 18 (11):827–8. doi: 10.1038/s41575-021-00522-5.
   PubMed Web of Science ®Google Scholar
• Scarpellini, E., E. Rinninella, M. Basilico, E. Colomier, C. Rasetti, T. Larussa, P. Santori, and L. Abenavoli. 2021. From pre- and probiotics to post-biotics: A narrative review. International Journal of Environmental Research and Public Health 19 (1):37. doi: 10.3390/ijerph19010037.
   PubMed Web of Science ®Google Scholar
• Sivamaruthi, B. S., P. Kesika, and C. Chaiyasut. 2020. The role of probiotics in colorectal cancer management. Evidence-Based Complementary and Alternative Medicine 2020:3535982. doi: 10.1155/2020/3535982.
   PubMed Web of Science ®Google Scholar
• Stavropoulou, E., and E. Bezirtzoglou. 2020. Probiotics in medicine: A long debate. Frontiers in Immunology 11:2192. doi: 10.3389/fimmu.2020.02192.
   PubMed Web of Science ®Google Scholar
• Stoffel, E. M., and C. C. Murphy. 2020. Epidemiology and mechanisms of the increasing incidence of colon and rectal cancers in young adults. Gastroenterology 158 (2):341–53. doi: 10.1053/j.gastro.2019.07.055.
   PubMed Web of Science ®Google Scholar
• Suárez, N., F. Ferrara, A. Rial, V. Dee, and J. A. Chabalgoity. 2020. Bacterial lysates as immunotherapies for respiratory infections: Methods of preparation. Frontiers in Bioengineering and Biotechnology 8:545. doi: 10.3389/fbioe.2020.00545.
   PubMed Web of Science ®Google Scholar
• Suez, J., N. Zmora, E. Segal, and E. Elinav. 2019. The pros, cons, and many unknowns of probiotics. Nature Medicine 25 (5):716–29. doi: 10.1038/s41591-019-0439-x.
   PubMed Web of Science ®Google Scholar
• Sumransub, N., K. Vantanasiri, A. Prakash, and E. Lou. 2021. Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success? Molecular Therapy Oncolytics 22:1–12. doi: 10.1016/j.omto.2021.05.001.
   PubMed Web of Science ®Google Scholar
• Swanson, K. S., G. R. Gibson, R. Hutkins, R. A. Reimer, G. Reid, K. Verbeke, K. P. Scott, H. D. Holscher, M. B. Azad, N. M. Delzenne, et al. 2020. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. Nature Reviews. Gastroenterology & Hepatology 17 (11):687–701. doi: 10.1038/s41575-020-0344-2.
   PubMed Web of Science ®Google Scholar
• Szentirmai, É., N. S. Millican, A. R. Massie, and L. Kapás. 2019. Butyrate, a metabolite of intestinal bacteria, enhances sleep. Scientific Reports 9 (1):7035. doi: 10.1038/s41598-019-43502-1.
   PubMedGoogle Scholar
• Taghinezhad, S., A. H. Mohseni, and X. Fu. 2021. Intervention on gut microbiota may change the strategy for management of colorectal cancer. Journal of Gastroenterology and Hepatology 36 (6):1508–17.
   PubMed Web of Science ®Google Scholar
• Tahmourespour, A., A. Ahmadi, and M. Fesharaki. 2020. The anti-tumor activity of exopolysaccharides from Pseudomonas strains against HT-29 colorectal cancer cell line. International Journal of Biological Macromolecules 149:1072–6. doi: 10.1016/j.ijbiomac.2020.01.268.
   PubMed Web of Science ®Google Scholar
• Teame, T., A. Wang, M. Xie, Z. Zhang, Y. Yang, Q. Ding, C. Gao, R. E. Olsen, C. Ran, and Z. Zhou. 2020. Paraprobiotics and postbiotics of probiotic Lactobacilli, their positive effects on the host and action mechanisms: A review. Frontiers in Nutrition 7:570344. doi: 10.3389/fnut.2020.570344.
   PubMed Web of Science ®Google Scholar
• Tripathy, A., J. Dash, S. Kancharla, P. Kolli, D. Mahajan, S. Senapati, and M. K. Jena. 2021. Probiotics: A promising candidate for management of colorectal cancer. Cancers 13 (13):3178. doi: 10.3390/cancers13133178.
   PubMed Web of Science ®Google Scholar
• Tukenmez, U., B. Aktas, B. Aslim, and S. Yavuz. 2019. The relationship between the structural characteristics of lactobacilli-EPS and its ability to induce apoptosis in colon cancer cells in vitro. Scientific Reports 9 (1):8268. doi: 10.1038/s41598-019-44753-8.
   PubMedGoogle Scholar
• Tyrrell, D., P. Nolan, S. E. Reed, and M. Healy. 1972. Trial of an oral bacterial antigen against common colds. British Journal of Preventive & Social Medicine 26 (2):129–31. doi: 10.1136/jech.26.2.129.
   PubMedGoogle Scholar
• Vrzáčková, N., T. Ruml, and J. Zelenka. 2021. Postbiotics, metabolic signaling, and cancer. Molecules 26 (6):1528. doi: 10.3390/molecules26061528.
   PubMed Web of Science ®Google Scholar
• Wang, P. X., X. R. Deng, C. H. Zhang, and H. J. Yuan. 2020. Gut microbiota and metabolic syndrome. Chinese Medical Journal 133 (7):808–16. doi: 10.1097/cm9.0000000000000696.
   PubMed Web of Science ®Google Scholar
• Warda, A. K., A. G. Clooney, F. Ryan, P. H. de Almeida Bettio, G. Di Benedetto, R. P. Ross, and C. Hill. 2021. A postbiotic consisting of heat-treated lactobacilli has a bifidogenic effect in pure culture and in human fermented faecal communities. Applied and Environmental Microbiology 87 (8):e02459-20. doi: 10.1128/AEM.02459-20.
   Web of Science ®Google Scholar
• Wegh, C. A. M., S. Y. Geerlings, J. Knol, G. Roeselers, and C. Belzer. 2019. Postbiotics and their potential applications in early life nutrition and beyond. International Journal of Molecular Sciences 20 (19):4673. doi: 10.3390/ijms20194673.
   PubMed Web of Science ®Google Scholar
• Wu, C. W.-K, and R. N. Lui. 2022. Early-onset colorectal cancer: Current insights and future directions. World Journal of Gastrointestinal Oncology 14 (1):230–41.
   PubMed Web of Science ®Google Scholar
• Xie, Y.-H., Y.-X. Chen, and J.-Y. Fang. 2020. Comprehensive review of targeted therapy for colorectal cancer. Signal Transduction and Targeted Therapy 5 (1):22. doi: 10.1038/s41392-020-0116-z.
   PubMed Web of Science ®Google Scholar
• Zakostelska, Z., M. Kverka, K. Klimesova, P. Rossmann, J. Mrazek, J. Kopecny, M. Hornova, D. Srutkova, T. Hudcovic, J. Ridl, et al. 2011. Lysate of probiotic Lactobacillus casei DN-114 001 ameliorates colitis by strengthening the gut barrier function and changing the gut microenvironment. PLoS One 6 (11):e27961. doi: 10.1371/journal.pone.0027961.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., Z. Chen, and J. Li. 2017. The current status of treatment for colorectal cancer in China: A systematic review. Medicine 96 (40):e8242. doi: 10.1097/md.0000000000008242.
   PubMed Web of Science ®Google Scholar
• Zhuo, Q., B. Yu, J. Zhou, J. Zhang, R. Zhang, J. Xie, Q. Wang, and S. Zhao. 2019. Lysates of Lactobacillus acidophilus combined with CTLA-4-blocking antibodies enhance antitumor immunity in a mouse colon cancer model. Scientific Reports 9 (1):20128. doi: 10.1038/s41598-019-56661-y.
   PubMedGoogle Scholar
• Żółkiewicz, J., A. Marzec, M. Ruszczyński, and W. Feleszko. 2020. Postbiotics – A step beyond pre- and probiotics. Nutrients 12 (8):2189. doi: 10.3390/nu12082189.
   PubMed Web of Science ®Google Scholar